Jeffrey L. Ives
Director, Tvardi Therapeutics, Inc.
Companies
- Acumen Pharmaceuticals, Inc.Board member Jun 30, 2021 to now1
- Tvardi Therapeutics, Inc.Board member Jul 18, 2014 to Jun 6, 20242
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Tvardi Therapeutics, Inc. TVRD198,485 shares3$197.3K at $0.99Jun 4, 2024
- Acumen Pharmaceuticals, Inc. ABOS48,300 shares4$84.5K at $1.75Jun 3, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 3, 2026Granted 35,500 shares of Acumen Pharmaceuticals, Inc.4
- Jun 4, 2025Granted 12,800 shares of Acumen Pharmaceuticals, Inc.5
- Jun 4, 2024Granted 150,647 shares of Tvardi Therapeutics, Inc.3
- Aug 17, 2023Sold 2,800 shares at $6.66 of Acumen Pharmaceuticals, Inc.6
- Aug 17, 2023Exercised options 2,800 shares at $1.19 of Acumen Pharmaceuticals, Inc.6
- Aug 17, 2023Sold 39,149 shares at $6.48 of Acumen Pharmaceuticals, Inc.6
- Aug 17, 2023Exercised options 39,149 shares at $0.72 of Acumen Pharmaceuticals, Inc.6
- Jun 1, 2023Granted 32,362 shares of Tvardi Therapeutics, Inc.7
- Jul 15, 2022Sold 3,600 shares at $9.05 of Tvardi Therapeutics, Inc.8
- Jun 2, 2022Granted 11,876 shares of Tvardi Therapeutics, Inc.9
- Nov 12, 2021Sold 8,180 shares at $16.04 of Tvardi Therapeutics, Inc.10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Jun 5, 2025
- 6SEC EDGARForm 4 filed Aug 18, 2023
- 7SEC EDGARForm 4 filed Jun 5, 2023
- 8SEC EDGARForm 4 filed Jul 19, 2022
- 9SEC EDGARForm 4 filed Jun 6, 2022
- 10SEC EDGARForm 4 filed Nov 16, 2021